
Magdiclo 75mg Injection
Marketer
Magma Allianz Laboratories Ltd
Salt Composition
Diclofenac (75mg)
Overview Magdiclo 75mg Injection
ArthroMed 75mg Injection provides analgesia. Indicated for pain, inflammation, rigidity, and arthralgia associated with rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma, it's administered parenterally when oral intake is infeasible. Injection must be given by a qualified healthcare provider; self-administration is prohibited. Pre-existing cardiovascular disease or cerebrovascular accident history should be disclosed to your physician. Report any injection site reactions (pain, edema, erythema) immediately. Common adverse effects encompass nausea, emesis, cephalgia, and injection site responses. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with blood counts. Chronic use carries a risk of significant complications including gastrointestinal hemorrhage and nephropathy.
Uses of Magdiclo 75mg Injection
Analgesia
Major Benefits of Magdiclo 75mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
Common Side effects of Magdiclo 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Magdiclo 75mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Magdiclo 75mg Injection works:
Magdiclo 75mg Injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of specific inflammatory mediators responsible for pain and the associated redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Magdiclo 75mg Injection and alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Magdiclo 75mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in critical medical circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Magdiclo 75mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Magdiclo 75mg Injection may result in adverse reactions that could impair driving ability.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Magdiclo 75mg Injection. Dosage modification of Magdiclo 75mg Injection may be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, Magdiclo 75mg Injection requires careful administration. Dosage modification of Magdiclo 75mg Injection might be necessary. Physician consultation is recommended.
What if you forget to take Magdiclo 75mg Injection :
Omit a dose of Magdiclo 75mg Injection? Seek medical advice immediately.
Facts to Know About Magdiclo 75mg Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylacetic Acid Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relief Medications |
